Home / AARTIPHARM.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AARTIPHARM.NS make money? Does AARTIPHARM.NS have pricing power? What's the Earnings Whisper? Will AARTIPHARM.NS profit more as the business scales? What is AARTIPHARM.NS's management track record? Is AARTIPHARM.NS's current price justified?

Aarti Pharmalabs Limited

₹873.65 +$129.45 (+17.39%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹863.8

Day Range

₹864.85₹890.65

Year Range

₹585₹1002.4

Market Cap

79.22B

AVG Volume

658.66K

Trailing/Forward PE

37.16/34.26

PEG ratio

0.86

Dividend Yield

0.40%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

AARTIPHARM.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	5.36B
26 Q4	5.83B
26 Q3	4.32B
26 Q2	4.18B
26 Q1	3.86B
25 Q4	5.64B
25 Q3	5.38B
25 Q2	4.58B
25 Q1	5.55B
24 Q4	5.06B

Net Income (INR) · Q

AARTIPHARM.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	761.43M
26 Q4	611.24M
26 Q3	479.56M
26 Q2	279.23M
26 Q1	495.01M
25 Q4	883.41M
25 Q3	739.88M
25 Q2	546.23M
25 Q1	554.53M
24 Q4	652.52M

Operating Income (INR) · Q

AARTIPHARM.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	1.03B
26 Q4	1.02B
26 Q3	736.91M
26 Q2	499.5M
26 Q1	724.5M
25 Q4	1.23B
25 Q3	1.06B
25 Q2	727.9M
25 Q1	762.93M
24 Q4	984M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Aarti Pharmalabs Limited

Video analysis: AARTIPHARM.NS

News: AARTIPHARM.NS

Similar companies